Duygu Orak

Duygu Orak

Auto-generated profile, based on publicly available information

Duygu Orak

Yeditepe University, Faculty of Pharmacy, Drug, Cosmetic and Medical Device Research-Development and Analysis Laboratory, Istanbul, Turkey

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2020 in Saudi Pharmaceutical Journal
Verified
Journal Article
Open access
MOMehmet Evren Okur
Mehmet Evren Okur
SASule Ayla
Sule Ayla
VYVildan Yozgatlı
Vildan Yozgatlı
BABuket Aksu
Buket Aksu
AYAyşegül Yoltaş
Ayşegül Yoltaş
Neslihan Üstündağ OkurNeslihan Üstündağ Okur
Neslihan Üstündağ Okur
The objective of the present research was to examine the possible usage of microemulsion based gel for fusidic acid (FA) dermal application as burn wound treatment. During the preparation of microemulsion, ethyl oleate as oil phase, tween 80 as a surfactant, ethanol as co-surfactant, water as aqueous phase were used. The prepared microemulsions were evaluated for clarity, pH, viscosity and FA content. Moreover, stability, sterility, antibacterial activity, in vitro release of the formulations were also evaluated. The results showed that the FA loaded microemulsion and microemulsion based gel formation and characteristics were related to many parameters of the components. The performed optimized microemulsion-based gel showed good stability over a period of 3 months. The antibacterial activity of microemulsion-based gel was found to be comparable with marketed cream. RAW 264.7 macrophages were used to determine cell viability (MTT assay) and nitric oxide production. MBG and FA-MBG significantly inhibit the production of the inflammatory mediator NO in LPS-stimulated RAW 264.7 cells in a concentration-dependent manner. The wound healing property was evaluated by histopathological examination and by measuring the wound contraction. The % of wound area in rats treated with FA (2%) loaded microemulsion based gel ranged from 69.30% to 41.39% in the period from 3 to 10 days. In conclusion, FA loaded microemulsion based gel could be offered as encouraging strategy as dermal systems for the burn wound treatment.

1 September 2019 in South African Journal of Botany
Verified
Journal Article
Open access
AKA.E. Karadağ
A.E. Karadağ
FDfatih demirci
fatih demirci
AÇA. Çaşkurlu
A. Çaşkurlu
FDfatih demirci
fatih demirci
MOMehmet Evren Okur
Mehmet Evren Okur
KBK.H.C. Başer
K.H.C. Başer

1 April 2022 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
Hande SipahiHande Sipahi
Hande Sipahi
DODuygu Orak
Duygu Orak
RRRengin Reis
Rengin Reis
KYKübra Yalman
Kübra Yalman
OŞOnur Şenol
Onur Şenol
EYErdem Yesilada
Erdem Yesilada

21 April 2020 in Archiv der Pharmazie
Verified
Journal Article
Closed access
PDF file
TOTugce Ozyazici
Tugce Ozyazici
EGEnise E. Gurdal
Enise E. Gurdal
DODuygu Orak
Duygu Orak
Hande SipahiHande Sipahi
Hande Sipahi
TETuba Ercetin
Tuba Ercetin
MKMeric Koksal
Meric Koksal

13 May 2020 in Pharmaceutical Development and Technology
Verified
Journal Article
Closed access
IEİpEk Erol
İpEk Erol
Neslihan Üstündağ OkurNeslihan Üstündağ Okur
Neslihan Üstündağ Okur
DODuygu Orak
Duygu Orak
Hande SipahiHande Sipahi
Hande Sipahi
AAAhmet Aydın
Ahmet Aydın
OOOzgen Ozer
Ozgen Ozer
Psoriasis is a chronic autoinflammatory disorder characterized by patches of abnormal skin. For psoriasis management, the application of topical retinoids as Tazarotene is recommended. However, Tazarotene could induce skin irritation limiting its use. Herein, it is evaluated the possible usage of in situ gels for tazarotene skin delivery. The topical in situ gels were developed using thermosensitive poloxamers via cold method. They were examined for their appearance, sol-gel temperature, clarity, pH, viscosity, in vitro release and stability. Their biocompatibility was evaluated by investigating their cytotoxicity and irritation inducing capacity. The possible anti-inflammatory and analgesic activities were determined by measuring the nitric oxide and prostaglandin E2 levels production in LPS-stimulated RAW264.7 murine macrophage cells. It was revealed that the in situ gels had no cytotoxic effect (∼95-100% cell viability) and nor irritation potential (∼97% cell viability), according to the in vitro EpiDerm™ reconstituted skin irritation test. Additionally, the 10% tazarotene-in situ gels showed possible analgesic activity since the production of prostaglandin E2 (PGE2) was decreased. In further, both concentrations of 5% and 10% tazarotene-in situ gels inhibited significantly the nitrite oxide production at 16% and 19%, respectively. Finally, the prepared in situ gels can act as a potential non-irritant alternative option for tazarotene topical skin delivery.